LZAGY LONZA GROUP AG UNSP ADR EACH REP 0.1 ORD
- 57.250
- -0.540-0.93%
LONZA GROUP AG UNSP ADR EACH REP 0.1 ORD News
Lonza Prices EUR 1 Billion Straight Bond With a 3.875% Coupon
Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon Basel, Switzerland, 17 April 2024 – Lonza Finance International NV, a wholly owned company of Lonza Group Ltd, Basel ("Lonza"), announced
Lonza Group AG's (VTX:LONN) Largest Shareholders Are Individual Investors With 56% Ownership, Institutions Own 44%
Lonza Appoints New CEO
Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
Wednesday, Roche Holding AG (OTC:RHHBY) entered into a definitive agreement with Lonza Group Ltd (OTC:LZAGF) (OTC:LZAGY).Under the agreement, Lonza will acquire the Genentech manufacturing facility in
UPDATE 1-Luxury Stocks Drag European Equities Lower Ahead of Fed Meeting
UPDATE 1-Lonza to Buy Biologics Site From Roche in U.S. for $1.2 Bln
Lonza to Buy Biologics Site From Roche in U.S. for $1.2 Billion
Lonza Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) From Roche
Lonza Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from RocheLonza has signed an agreement to acquire the Genentech manufacturing facility in Vacaville (US) from Roche for U
Lonza Group's (VTX:LONN) Five-year Earnings Growth Trails the Favorable Shareholder Returns
Eli Lilly's Donanemab Nears Approval Decision, Could This Be a Turning Point in Alzheimer's Treatment?
The pharma giant Eli Lilly is on the cusp of a significant breakthrough with its Alzheimer's drug, donanemab.
Booming Weight-loss Drug Market to Lift "pick-and-shovel" Plays: Jefferies
Lonza Group AG (LZAGY) Q4 2023 Earnings Call Transcript Summary
The following is a summary of the Lonza Group AG (LZAGY) Q4 2023 Earnings Call Transcript:Financial Performance:Lonza reported group sales of CHF 6.7 billion in 2023, showing a growth of 10.9%.Profits
Lonza Group AG Non-GAAP EPS of CHF12.39, Revenue of CHF6.72B
Lonza Names Heineken's Jean-Marc Huet as Next Chairman
Lonza Group has proposed Jean-Marc Huet, currently chairman of Dutch brewer Heineken, as its next chair to replace Albert Baehny.
Lonza Sees Flat Sales in 2024
Lonza Group said it expects sales growth to be flat in 2024, after it reported sharply lower earnings despite higher revenue for last year due to continued investments.
Lonza Erzielt Im 2023 Ein Solides Ergebnis Mit 10.9% (KWk) Umsatzwachstum Und 29.8% Kern-EBITDA-Marge
Lonza erzielt im 2023 ein solides Ergebnis mit 10.9% (kWk) Umsatzwachstum und 29.8% Kern-EBITDA-MargeRobuster Umsatz von CHF 6.7 Milliarden, mit einem Umsatzwachstum von 10.9%1 (kWk) Kern-EBITDA von C
Notable Earnings Before Friday's Open
Lonza Not Planning to Manufacture GLP-1 Drugs: Report
Lonza Launches GS Effex Cell Line for the Development of Therapeutic Antibodies With Increased Potency
Lonza Launches GS Effex Cell Line for the Development of Therapeutic Antibodies with Increased Potency New cell line designed to help overcome challenges in immunotherapy research and development rela
Lonza Prices CHF 400 Million Dual-Tranche Straight Bonds
Lonza Prices CHF 400 Million Dual-Tranche Straight Bonds Basel, Switzerland, 06 November 2023 – Lonza Swiss Finance Ltd, a wholly owned company of Lonza Group Ltd, Basel ("Lonza"), announced today the
Analysis
Price Target
No Data
